All stock lists
Unlock the score
Cel Sci Corp (New York Stock Exchange Arca:CVM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.59-0.05 (-3.05%)
Market cap
$28.0M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 8, 1983
Website
Insider Score
/ 100
CVM Insider Score
CEL SCI CORP has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
CVM analyst forecast
Best analysts covering CVM
No firm covering CVM has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CVM analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | EF Hutton | Buy | — | — | Reiterated | 2023-07-12 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-03-09 |
| — | EF Hutton | Buy | — | — | Reiterated | 2022-12-29 |
| — | EF Hutton | Buy | — | — | Reiterated | 2022-08-25 |
| — | EF Hutton | Buy | — | — | Reiterated | 2022-04-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-01-13 |
| — | H.C. Wainwright | Buy | — | — | Reiterated | 2020-01-13 |
| — | Taglich Brothers | Buy | — | — | Reiterated | 2013-02-20 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2013-02-13 |
| — | Laidlaw & Co. | Buy | — | — | Reiterated | 2013-01-14 |
CVM earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | 0.00 | -0.68 | $0 | $0 |
| 2026-05-18 | 0.00 | -0.67 | $0 | $0 |
| 2026-08-14 | 0.00 | -0.47 | $0 | $0 |
| 2026-12-23 | 0.00 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.